Research and analysis

Dubai - Arab Health 2015 - Background Brief

Published 26 January 2015

This research and analysis was withdrawn on

This publication was archived on 5 August 2016. This article is no longer current. Please refer to Overseas Business Risk - United Arab Emirates.

© Crown copyright 2015

This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.

Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.

This publication is available at https://www.gov.uk/government/publications/dubai-arab-health-2015-background-brief/dubai-arab-health-2015-background-brief

0.1 This publication was archived on 5 August 2016.

This article is no longer current. Please refer to Overseas Business Risk - United Arab Emirates.

0.2 Summary

Arab Health 2015 will take place in Dubai from 26-29 January. Earl Howe, Lord Kakkar and Arlene Foster will lead a UK delegation of over 200 companies. The UK will be showcased as a world leader in the design, development and operation of healthcare infrastructure, products and services.

0.3 Detail

Earl Howe, England Health Minister (at his third Arab Health), Lord Kakkar, Business Ambassador, and Arlene Foster, Northern Ireland Minister of Enterprise will lead a strong delegation of academic and clinical institutions to Arab Health, which takes place in Dubai from 26 to 29 January 2015.

The congress and trade show is one of the largest in the world with a regional and global reach. Over 200 UK companies will be exhibiting, the UK’s largest ever presence. These will include Health Education England, University College London (UCL) Medical School, Skills for Health, Imperial College London, Great Ormond Street, King’s College Hospital, Queen’s University Belfast, Royal Free Hospital, Leeds Teaching Hospitals, Moorfields and the Devolved Adminstrations.

Our high level representation will seek to:

  • Promote UK expertise in the healthcare industry.

  • Increase the UK’s share of the growing global healthcare market.

  • Focus on expanding our market share in the Middle East healthcare market taking advantage of the rapid growth in investment which is expected to be worth $60 billion by 2025.

  • Support wider HMG initiatives to develop deeper linkages between Great Britain, Northern Ireland and the Republic of Ireland through a joint networking reception.

Our activities will include:

  • One to one meetings with senior Emiratis and Gulf Ministers of State.

  • Delivering proposition workshops showcasing the UK’s healthcare “offer” on clinical services, education and training and genetics/personalised medicine.

  • Hosting a joint UK/Irish/Northern Ireland Healthcare Networking Event – fulfilling a commitment made by the Prime Minister and Taoiseach.

  • A meeting of the UK-UAE Healthcare working group as part of the UAE-UK Business Council – the working group is key to helping develop relationships with Emirati partners, investors and customers.

  • An inward mission from South East Asia as part of our GREAT activities, focussing on strategic planning and consultancy.

0.4 Comment

Our high level delegation will give a timely boost to what we hope will be the next phase of UK-UAE collaboration on healthcare, as well as increase our global footprint as a world leader in healthcare provision. We will report outcomes next week, following the congress.

0.5 Disclaimer

The purpose of the FCO Country Update(s) for Business (”the Report”) prepared by UK Trade & Investment (UKTI) is to provide information and related comment to help recipients form their own judgments about making business decisions as to whether to invest or operate in a particular country. The Report’s contents were believed (at the time that the Report was prepared) to be reliable, but no representations or warranties, express or implied, are made or given by UKTI or its parent Departments (the Foreign and Commonwealth Office (FCO) and the Department for Business, Innovation and Skills (BIS)) as to the accuracy of the Report, its completeness or its suitability for any purpose. In particular, none of the Report’s contents should be construed as advice or solicitation to purchase or sell securities, commodities or any other form of financial instrument. No liability is accepted by UKTI, the FCO or BIS for any loss or damage (whether consequential or otherwise) which may arise out of or in connection with the Report.

Back to top